SEC Form 4 · accession 0001144204-16-116709
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Kazado
Director
Period of report
Aug 4, 2016
Accepted (ET)
Aug 4, 2016 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 4, 2016 | P | 666,667 | $0.45 | A | 907,290 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued upon repayment of a $300,000 promissory note at the conversion price of $0.45 per share.